Brainsway Valuation
| BRIN Stock | 1,761 34.00 1.89% |
At this time, the firm appears to be overvalued. Brainsway shows a prevailing Real Value of 1413.51 per share. The current price of the firm is 1761.0. Our model approximates the value of Brainsway from analyzing the firm fundamentals such as ebitda of (3.89 M), and Cash Per Share of 0.55 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Brainsway's price fluctuation is very steady at this time. Calculation of the real value of Brainsway is based on 3 months time horizon. Increasing Brainsway's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Brainsway is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brainsway Stock. However, Brainsway's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1761.0 | Real 1413.51 | Hype 1761.0 | Naive 1787.95 |
The real value of Brainsway Stock, also known as its intrinsic value, is the underlying worth of Brainsway Company, which is reflected in its stock price. It is based on Brainsway's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Brainsway's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Brainsway helps investors to forecast how Brainsway stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brainsway more accurately as focusing exclusively on Brainsway's fundamentals will not take into account other important factors: Brainsway Total Value Analysis
Brainsway is currently forecasted to have takeover price of 0 with market capitalization of 334.31 M, debt of 2.83 M, and cash on hands of 9.07 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Brainsway fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 334.31 M | 2.83 M | 9.07 M |
Brainsway Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Brainsway suggests not a very effective usage of assets in November.Brainsway Profitability Analysis
Net Income was 0 with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Brainsway's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Brainsway and how it compares across the competition.
About Brainsway Valuation
The stock valuation mechanism determines Brainsway's current worth on a weekly basis. Our valuation model uses a comparative analysis of Brainsway. We calculate exposure to Brainsway's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Brainsway's related companies.Brainsway Ltd. engages in the development and provision of technology solutions for non-invasive treatment of brain disorders in Israel and internationally. Brainsway Ltd. was founded in 2003 and is based in Jerusalem, Israel. Brainsway Ltd operates under Diagnostics Research classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 96 people.
8 Steps to conduct Brainsway's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Brainsway's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Brainsway's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Brainsway's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Brainsway's revenue streams: Identify Brainsway's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Brainsway's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Brainsway's growth potential: Evaluate Brainsway's management, business model, and growth potential.
- Determine Brainsway's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Brainsway's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Brainsway Stock analysis
When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |